<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurochem Res</journal-id><journal-id journal-id-type="iso-abbrev">Neurochem Res</journal-id><journal-title-group><journal-title>Neurochemical Research</journal-title></journal-title-group><issn pub-type="ppub">0364-3190</issn><issn pub-type="epub">1573-6903</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39607552</article-id><article-id pub-id-type="pmc">PMC11604774</article-id>
<article-id pub-id-type="publisher-id">4294</article-id><article-id pub-id-type="doi">10.1007/s11064-024-04294-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Oxytocin Protects Against Corticosterone-Induced DA Dysfunction: An Involvement of the PKA/CREB Pathway</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chaipunko</surname><given-names>Sirinun</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sookkua</surname><given-names>Tichaporn</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nopparat</surname><given-names>Chutikorn</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chutabhakdikul</surname><given-names>Nuanchan</given-names></name><address><email>nuanchan.chu@mahidol.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01znkr924</institution-id><institution-id institution-id-type="GRID">grid.10223.32</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0490</institution-id><institution>Research Center for Neuroscience, Institute of Molecular Biosciences, </institution><institution>Mahidol University, </institution></institution-wrap>Nakhon Pathom, 73170 Thailand </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01znkr924</institution-id><institution-id institution-id-type="GRID">grid.10223.32</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0490</institution-id><institution>Faculty of Physical Therapy, </institution><institution>Mahidol University, </institution></institution-wrap>Nakhon Pathom, 73170 Thailand </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/004z16v08</institution-id><institution-id institution-id-type="GRID">grid.443752.3</institution-id><institution-id institution-id-type="ISNI">0000 0000 8886 3206</institution-id><institution>Faculty of Physical Therapy, </institution><institution>Saint Louis College, </institution></institution-wrap>Bangkok, 10120 Thailand </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04718hx42</institution-id><institution-id institution-id-type="GRID">grid.412739.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9006 7188</institution-id><institution>Innovative Learning Center, </institution><institution>Srinakharinwirot University, </institution></institution-wrap>Bangkok, 10110 Thailand </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>50</volume><issue>1</issue><elocation-id>38</elocation-id><history><date date-type="received"><day>24</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>15</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Chronic stress disrupts dopamine (DA) transmission, adversely affecting mood and contribution to neuropsychiatric disorders like ADHD, autism, schizophrenia, anxiety, depression, and drug addiction. The neuropeptide oxytocin (OXT) plays a key role in social cognition, bonding, attachment, and parenting behaviors. In addition, OXT can modulate the activity of the HPA axis, counteracting the effects of stress, and alleviating fear and anxiety. However, whether OXT can mitigate stress-induced DA dysfunction and the underlying mechanisms remains unclear. This study investigated the neuroprotective effects of OXT on corticosterone (CORT) induced DA dysfunction in the neuroblastoma cell line SH-SY5Y. The results revealed that CORT decreases the levels of intracellular signaling molecules associated with DA function, including phosphorylated tyrosine hydroxylase (pTH), phosphorylated cAMP response element-binding protein (pCREB), and protein kinase A (PKA). Interestingly, pretreatment with OXT mitigated CORT-induced DA dysfunction through its potent PKA activator properties. In addition, the neuroprotective effect of OXT was abolished by atosiban (an OXT receptor antagonist) or H89 (a PKA inhibitor). Our results suggest that OXT protects dopaminergic neuroblastoma cells from CORT-induced DA dysfunction, potentially through the involvement of oxytocin receptors and the PKA/CREB signaling pathway. These findings contribute to the understanding of the neurobiological mechanisms underlying stress resilience and highlight potential pathways for developing targeted treatments that leverage the neuroprotective properties of OXT to address disorders characterized by DA dysregulation and impaired stress responses.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Oxytocin</kwd><kwd>Stress</kwd><kwd>Dopamine</kwd><kwd>Tyrosine hydroxylase</kwd><kwd>PKA/CREB</kwd><kwd>SH-SY5Y cells</kwd></kwd-group><funding-group><award-group><funding-source><institution>Mahidol University</institution></funding-source></award-group><open-access><p>Open access funding provided by Mahidol University</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Stress activates the hypothalamus-pituitary-adrenal (HPA) axis, resulting in corticosteroid (CORT) secretion. Normally, this helps restore homeostasis [<xref ref-type="bibr" rid="CR1">1</xref>]. However, chronic stress dysregulates the HPA axis, leading to persistently elevated CORT levels and contributing to mental illness and stress-related brain disorders [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Stress has a significant impact on dopamine function, which is crucial for mental health. Chronic stress can lead to alterations in dopamine signaling pathways, potentially contributing to the development of mental disorders such as depression, anxiety, and schizophrenia [<xref ref-type="bibr" rid="CR4">4</xref>]. Understanding these changes is essential for developing effective interventions and treatments for stress-related mental health issues.</p><p id="Par3">Dopamine (DA) has diverse functions across various brain regions. In the prefrontal cortex, DA regulates cognition and executive functions such as working memory, attention, and decision-making [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. In the limbic system, DA is crucial for processing rewards, pleasure, motivation, and reinforcement learning [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Impairments in DA function are associated with learning and memory deficits and contribute to psychiatric conditions such as schizophrenia, autism, ADHD, and drug addiction [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Evidence for DA dysfunction includes disturbances in tyrosine hydroxylase (TH) activity. Animal models have shown a decrease in TH expression in the substantia nigra and the striatum in ADHD-induced rats [<xref ref-type="bibr" rid="CR11">11</xref>]. Additionally, selectively lesioning the striatum and affecting TH-expressing interneurons leads to impaired goal-directed behavior in mouse models [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par4">Stress negatively impacts mesolimbic dopamine function and affects social behaviors [<xref ref-type="bibr" rid="CR13">13</xref>]. Chronic stress, for example, is strongly associated with disrupted dopamine signaling in the medial prefrontal cortex and ventral striatum, affecting reward sensitivity [<xref ref-type="bibr" rid="CR14">14</xref>] and reward learning [<xref ref-type="bibr" rid="CR15">15</xref>]. Recent findings by Quessy et al. (2021) revealed that chronic stress induces morphological and molecular changes in dopaminergic neurons in both the mesolimbic and mesocortical pathways. These changes are accompanied by a significant reduction in dopamine synthesis in the ventral striatum, contributing to depressive-like behaviors in rodent models [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. These lines of evidence suggest that stress disrupts dopamine transmission, leading to adverse effects on mood and behavior. Additionally, stress is a risk factor that can trigger the initiation, escalation, and relapse of drug addiction through dopaminergic mechanisms [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par5">Oxytocin (OXT) is a neuropeptide hormone crucial for various physiological processes. Peripherally, OXT facilitates newborn delivery, milk ejection, and parenting behaviors [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>]. Centrally, OXT is associated with higher-order cognitive processes such as social attachment and bonding [<xref ref-type="bibr" rid="CR21">21</xref>]. Additionally, OXT administration has shown potential for improving social deficits in animal models of autism and schizophrenia [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Consequently, OXT is considered a promising neuromodulator for therapeutic strategies targeting stress-induced psychiatric disorders and mental illnesses, which may result from chronic stress influencing dopaminergic dysregulation [<xref ref-type="bibr" rid="CR23">23</xref>]. Interestingly, OXT administration reportedly enhances attention and social behavior and reduces stress [<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. Although OXT is a critical modulator of HPA axis activity and related neural pathways [<xref ref-type="bibr" rid="CR26">26</xref>], the mechanisms underlying its modulation of stress-induced dopamine neuron dysfunction remain unclear. Various stressful stimuli activate oxytocin neurons and facilitate OXT release, modulating the stress response in animal model studies. This process involves OXT receptor activation in several distinct brain regions [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par6">Oxytocin and dopamine share similarities in their organization and projection sites. For example, DA receptors are present in OXT neurons, and OXT receptors are found in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc). OXT appears to directly increase the activity of VTA neurons and indirectly inhibit SNc dopaminergic neurons. OXT and DA synergistically facilitate social behavior through the direct projections of VTA dopaminergic neurons to the ventral hippocampus and nucleus accumbens [<xref ref-type="bibr" rid="CR29">29</xref>]. These findings indicate that OXT modulates the activity of dopamine neurons in the VTA and substantia nigra, playing a crucial role in social behavior modulation [<xref ref-type="bibr" rid="CR30">30</xref>]. Understanding the mechanisms by which dopamine signaling interacts with the oxytocinergic system can be valuable for developing therapeutic strategies for conditions involving social deficits.</p><p id="Par7">The potential neuroprotective effect of OXT in mitigating the negative impact of stress on dopaminergic neurons and its underlying mechanisms are not yet fully understood and require further exploration. However, additional research is needed to investigate the signaling mechanisms through which OXT counteracts the toxic effects of CORT on dopaminergic function in vitro. Human neuroblastoma SH-SY5Y cells exhibit neuroblast-like characteristics similar to those of catecholaminergic neurons and express markers such as tyrosine hydroxylase (TH) and dopamine-&#x003b2;-hydroxylase (DBH) [<xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. To elucidate the intricate processes and signaling mechanisms through which OXT influences dopaminergic activity following exposure to a toxic dose of CORT, this study utilized the SH-SY5Y neuroblastoma cell line to investigate the effects of CORT on TH and CREB phosphorylation. We hypothesize that OXT can protect against corticosterone-induced neurotoxicity in SH-SY5Y cells possibly through the oxytocin receptor and the PKA/CREB signaling pathway.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Cell Culture</title><p id="Par8">Human neuroblastoma SH-SY5Y cells were cultured at a density of 1.5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/ml in basal medium supplemented with Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) supplemented with L-glutamine, sodium pyruvate, phenol red, 100 U/ml penicillin, 100&#x000a0;&#x000b5;g/ml streptomycin, and 10% Gibco<sup>&#x000ae;</sup> fetal bovine serum (all from Invitrogen, USA). The cells were incubated at 37&#x000a0;&#x000b0;C in a humidified atmosphere with 5% CO2. Once the cells reached confluency, they were passaged using gentle trypsinization with 0.25% trypsin-EDTA containing phenol red to detach the adhered cells. Trypsinization was halted by adding an equal volume of DMEM supplemented with 10% FBS. The culture medium was replaced with fresh medium every 24&#x000a0;h.</p></sec><sec id="Sec4"><title>Drugs and Reagents</title><p id="Par9">Corticosterone (CORT; product no. C2505), oxytocin (OXT; product no. O3251), a PKA inhibitor (H89; product no. B1427), and an OXT receptor antagonist (atosiban; product no. A3480) were obtained from Sigma&#x02012;Aldrich (St. Louis, MO, USA). The antibodies used for verification in this study included a &#x003b2;III-tubulin antibody (product no. SAB4500088), which was purchased from Sigma&#x02012;Aldrich; an anti-&#x003b2;-actin antibody (cat. no. SC-69879); and a monoclonal mouse anti-total tyrosine hydroxylase antibody (tTH, cat. no. SC-25269), which was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal rabbit anti-phospho-tyrosine hydroxylase (Ser40) antibody (pTH, Cat. No. 2791&#x000a0;S), monoclonal rabbit anti-phospho-cAMP-response-element-binding-protein (Ser133) antibody (pCREB; Cat. No. 9198&#x000a0;S), and polyclonal rabbit anti-catalytic-protein kinase A-&#x003b1; subunit antibody (PKAc-&#x003b1;; (Cat. No. 4782&#x000a0;S) were purchased from Cell Signaling Technology (Beverly, MA, USA). CORT was dissolved in dimethyl sulfoxide (DMSO), which was also acquired from Sigma&#x02012;Aldrich. All cell culture reagents were purchased from Invitrogen (Carlsbad, CA, USA).</p></sec><sec id="Sec5"><title>Cell Treatment</title><p id="Par10">SH-SY5Y cells were seeded into 6&#x000a0;mm Petri dishes in DMEM supplemented with 10% FBS for 24&#x000a0;h to study CORT-induced neurotoxicity and its effects on TH and CREB phosphorylation as well as PKA activity. The cells were treated with 400 &#x000b5;M CORT for 48&#x000a0;h. To assess whether OXT could protect cells from CORT-induced toxicity, cells were pretreated with 1 &#x000b5;M atosiban (an OTR antagonist) for 1&#x000a0;h, followed by 0.1 &#x000b5;M OXT for another hour before exposure to CORT. To investigate the involvement of PKA in OXT-mediated protection, cells were pretreated with 1 &#x000b5;M H89 for 30&#x000a0;min, followed by 0.1 &#x000b5;M OXT and subsequent CORT treatment (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> for the experimental design). All the experiments were conducted with a sample size of 4 (<italic>n</italic>&#x02009;=&#x02009;4), and each experiment was performed in duplicate.</p><p id="Par11">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Experimental design</p></caption><graphic xlink:href="11064_2024_4294_Fig1_HTML" id="d33e379"/></fig>
</p></sec><sec id="Sec6"><title>Western Blot/Immunoblotting</title><p id="Par12">After the cells were treated under various experimental conditions, they were collected and washed with cold 0.1&#x000a0;M PBS. The tissues were then homogenized and sonicated in lysis buffer containing 0.1&#x000a0;M NaCl, 0.01&#x000a0;M Tris-HCl (pH 7.6), 0.001&#x000a0;M EDTA (pH 8.0), 1&#x000a0;&#x000b5;g/ml aprotinin, 100&#x000a0;&#x000b5;g/ml phenylmethylsulfonyl fluoride (PMSF), and protease and phosphatase inhibitors. Following sonication, the samples were centrifuged at 14,000&#x000a0;rpm for 20&#x000a0;min. The supernatant, containing the soluble protein, was subjected to Western blot analysis. Protein concentrations were determined using a BCA Protein Assay Kit (Pierce, Rockford, IL) and a 96-well microplate reader (Spectra Max 340; Molecular Devices, Sunnyvale, CA). Samples containing 25&#x000a0;&#x000b5;g of protein were electrophoresed on a 10% SDS&#x02012;polyacrylamide gel and transferred to polyvinylidene fluoride (PVDF) membranes. The membranes were blocked with either 5% nonfat milk or 3% bovine serum albumin (BSA) in TBST at room temperature for 1&#x000a0;h. Subsequently, the PVDF membranes were incubated with the appropriate primary antibodies at 4&#x000a0;&#x000b0;C overnight. After washing three times with TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1&#x000a0;h at room temperature. The membranes were then washed to remove any nonspecific binding of secondary antibodies. Finally, the labeled protein bands were detected using Amersham ECL Prime Western Blotting Detection Reagent (G&#x00026;E Healthcare Bio-Sciences, Pittsburgh, USA) and visualized with a Bio-Rad<sup>&#x000ae;</sup> chemiluminescence detection system (Bio-Rad<sup>&#x000ae;</sup> ChemiDoc&#x02122; XRS<sup>+</sup> System). The values are presented as the percentage change in the optical density of each experimental condition relative to the sham control within individual blots.</p><p id="Par13">In this study, changes in the TH enzyme are presented as a ratio of phosphorylated TH (pTH) to total TH (tTH), as total TH levels can vary significantly across experimental conditions or cell types. This pTH/tTH ratio distinguishes phosphorylation effects from changes in protein expression. In contrast, the functionality of the CREB transcription factor is primarily attributed to its phosphorylated form (pCREB), particularly phosphorylation at serine 133, which is essential for its transcriptional activation [<xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par14">According to Rosethorne et al. (2008), total CREB levels in undifferentiated SH-SY5Y neuroblastoma cells generally remain at basal levels, supporting basic cellular functions like survival and signaling, with no significant changes observed across various treatment conditions [<xref ref-type="bibr" rid="CR35">35</xref>]. Similarly, differentiated SH-SY5Y cells also showed no significant differences in total CREB under different treatment conditions [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Therefore, in this study, we emphasize pCREB to capture its functional state, as pCREB levels alone are more relevant to understanding CREB&#x02019;s role in our experimental context.</p></sec><sec id="Sec7"><title>Statistical Analysis</title><p id="Par15">The data were calculated from 4 independent experiments, each conducted in duplicate. The data are presented as the means&#x02009;&#x000b1;&#x02009;SEMs. Statistical comparisons were conducted using one-way analysis of variance (ANOVA) followed by the Newman&#x02012;Keuls multiple comparison test. A probability value of <italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05 was considered to indicate statistical significance. All the statistical analyses were performed using GraphPad Prism<sup>&#x000ae;</sup> software version 8.0.1.</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><sec id="Sec9"><title>Determine the Optimal Doses of Drugs Treatment</title><p id="Par16">To examine the cytotoxic effect of corticosterone (CORT) on SH-SY5Y cells, the cells were exposed to varying concentrations of CORT (0, 80, 100, 200, 400, 600, 800, and 1,000 &#x000b5;M) for 48&#x000a0;h. Cell viability was assessed using the MTT assay (see Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The results demonstrated a dose-dependent reduction in cell viability, with higher concentrations of CORT leading to progressively greater cytotoxic effects. Based on these findings, 400 &#x000b5;M was chosen as the optimal dose for further experiments, as it induced a significant yet submaximal reduction in viability, making it suitable for investigating potential protective effects.</p><p id="Par17">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of CORT on SH-SY5Y cell viability. SH-SY5Y cells were exposed to increasing doses of CORT for 48&#x000a0;h. Cell viability was assessed using the MTT assay, showing a dose-dependent decrease in survival rate. Data are presented as mean&#x02009;&#x000b1;&#x02009;SEM from 3 independent experiments, each performed in triplicate. Statistical significance is indicated as ***<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.001 compared to the vehicle group</p></caption><graphic xlink:href="11064_2024_4294_Fig2_HTML" id="d33e437"/></fig>
</p><p id="Par18">To determine whether OXT could protect against CORT-induced cytotoxicity, SH-SY5Y cells were pretreated with increasing doses of OXT (0, 10&#x0207b;&#x02075;, 10&#x0207b;&#x02074;, 10&#x0207b;&#x000b3;, 10&#x0207b;&#x000b2;, 10&#x0207b;&#x000b9;, and 1 &#x000b5;M) for 1&#x000a0;h before exposure to 400 &#x000b5;M CORT for 48&#x000a0;h (see Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The MTT assay revealed a dose-dependent protective effect of OXT, with higher doses of OXT significantly improving cell viability compared to CORT treatment alone. The optimal dose of OXT for protection was found to be 10&#x0207b;&#x000b9; &#x000b5;M, as it provided the most significant improvement in cell viability. These findings suggest that OXT may counteract the toxic effects of CORT, potentially through mechanisms that support cell survival under stress conditions. Statistical analysis confirmed the significance of these protective effects, with <italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05, indicating the efficacy of OXT in enhancing cell viability. Additionally, a dose of 1.0 &#x000b5;M was chosen for both atosiban and H89 based on previous studies that identified this concentration as optimal for similar experimental conditions [<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par19">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Cell viability assay for the protective effect of OXT against CORT-induced toxicity in SH-SY5Y cells. SH-SY5Y cells were pretreated with increasing doses of OXT for 1&#x000a0;h before being exposed to 400 &#x000b5;M CORT for 48&#x000a0;h. Cell viability was assessed using the MTT assay. The data are presented as mean&#x02009;&#x000b1;&#x02009;SEM from 3 independent experiments, each performed in triplicate. Statistical significance is indicated as *<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05 compared to CORT alone, and <sup>###</sup><italic>p&#x02009;&#x0003c;</italic>&#x02009;0.001 compared to the vehicle group</p></caption><graphic xlink:href="11064_2024_4294_Fig3_HTML" id="d33e469"/></fig>
</p></sec><sec id="Sec10"><title>Oxytocin Protects against CORT-Induced DA Dysfunction in SH-SY5Y Cells</title><p id="Par20">This study explored the protective effects of OXT against CORT-induced DA dysfunction in SH-SY5Y cells. Forty-eight hours of exposure to a toxic dose of CORT (400 &#x000b5;M) led to a significant reduction in the pTH/tTH ratio by 49.67% compared to the control group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). However, pretreatment with OXT (0.1 &#x000b5;M) for 1&#x000a0;h reversed this effect, as shown by increasing the pTH/tTH ratio to 90.38% of the control group, and significant increase compared to the CORT-treated group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01). This protective effect of OXT was attenuated by pretreatment with OXT receptor antagonist, atosiban. Pretreatment with 1.0 &#x000b5;M atosiban significantly decreased the pTH/tTH ratio as compared to the control group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05) and OXT pretreatment group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05). Moreover, there was no significant difference in the pTH/tTH ratio between the atosiban-treated group and the CORT-treated group.</p><p id="Par21">In addition, OXT can protect against CORT-induced alterations in pCREB. Treatment of SH-SY5Y cells with a toxic dose of CORT for 48&#x000a0;h led to a significant decrease in pCREB levels by 60.18% compared to those in the control group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). Nonetheless, pretreatment with 0.1 &#x000b5;M OXT for 1&#x000a0;h effectively reversed this reduction, leading to a significant increase in pCREB levels compared to those in the CORT-treated group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05). The protective effect of OXT was compromised by pretreatment with the OXT receptor antagonist atosiban. Pretreatment with 1.0 &#x000b5;M atosiban notably reduced pCREB levels to those observed in the CORT-treated group. The atosiban-treated group exhibited a significant decrease in pCREB levels compared to those in the control (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05) and OXT-pretreated groups (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05). These findings indicate that CORT reduces TH and CREB phosphorylation but that this effect can be prevented by pretreatment with OXT. Additionally, the protective effects of OXT against CORT-induced decreases in pTH and pCREB occur through the OXTR signaling pathway.</p><p id="Par22">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Western blot analysis of tTH (<bold>a</bold>), pTH (<bold>b</bold>), pTH/tTH (<bold>c</bold>), and pCREB (<bold>d</bold>) expression in control, CORT-treated, OXT-pretreated, and atosiban&#x02009;+&#x02009;OXT-pretreated SH-SY5Y cells (<italic>n</italic>&#x02009;=&#x02009;4 per group). The intensity of the product bands was normalized against that of the respective internal controls. Bar graph displays the corresponding quantitative results. The data are expressed as a percentage of the control. The values represent means&#x02009;&#x000b1;&#x02009;SEMs. Statistical significance is denoted as *<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05 and **<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01</p></caption><graphic xlink:href="11064_2024_4294_Fig4_HTML" id="d33e538"/></fig>
</p></sec><sec id="Sec11"><title>OXT Counteracts CORT-Induced DA Dysfunction through a PKA-Dependent Mechanism</title><p id="Par23">To test the hypothesis that OXT pretreatment can prevent CORT-induced DA dysfunction via the PKA signaling pathway, we first examined whether OXT affects the level of PKAc-&#x003b1;, a key signaling molecule that can phosphorylate the CREB protein. The results showed that OXT is a powerful PKA activator. OXT alone significantly increased PKAc-&#x003b1; levels to 150% of the control level (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). Therefore, we further investigated the protective effects of OXT against CORT-induced alterations in PKAc-&#x003b1; in SH-SY5Y cells. Exposure to a toxic dose of CORT (400 &#x000b5;M) for 48&#x000a0;h significantly decreased PKAc-&#x003b1; levels compared to those in the control group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05). However, OXT pretreatment (0.1 &#x000b5;M) for 1&#x000a0;h effectively reversed this reduction by inducing a significant increase in PKAc-&#x003b1; levels compared to that in the CORT-treated group (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01); moreover, there was no significant difference compared with that in the control group. Furthermore, pretreatment with 1.0 &#x000b5;M H89 significantly reduced PKAc-&#x003b1; to the level observed in the CORT-treated group. The H89-treated group exhibited significantly lower PKAc-&#x003b1; levels than did the control (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05) and OXT-pretreated groups (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01) (see Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b). Our finding that the protective effects of OXT against the CORT-induced decrease in PKAc-&#x003b1; were abolished by the PKA inhibitor H89 provides important mechanistic insights into the molecular interaction between CORT and OXT. This finding suggested that OXT plays a direct regulatory role on PKAc-&#x003b1; in the presence of CORT.</p><p id="Par24">
<fig id="Fig5"><label>Fig. 5</label><caption><p>(<bold>a</bold>) Western blot analysis of PKAc-&#x003b1; in control and OXT-treated SH-SY5Y cells (<italic>n</italic>&#x02009;=&#x02009;4 per group) and (<bold>b</bold>) Western blot analysis of PKAc-&#x003b1; in control, CORT-treated, OXT-pretreated, and H89&#x02009;+&#x02009;OXT-pretreated SH-SY5Y cells (<italic>n</italic>&#x02009;=&#x02009;4 per group). The intensity of the product bands was normalized against that of the &#x003b2;III-tubulin band as an internal control. The bar graph displays the corresponding quantitative results. The data are expressed as a percentage of the control. The values represent the means&#x02009;&#x000b1;&#x02009;SEMs. Statistical significance is denoted as *<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05, **<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01, and ns&#x02009;=&#x02009;not significant difference</p></caption><graphic xlink:href="11064_2024_4294_Fig5_HTML" id="d33e594"/></fig>
</p><p id="Par25">Finally, we tested the hypothesis that OXT counteracts the CORT-induced decrease in pTH and pCREB levels through a PKA-dependent mechanism by pretreating SH-SY5Y cells with the PKA inhibitor H89. The results revealed that H89 significantly reversed the protective effect of OXT by reducing the pTH (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01; Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a) and pCREB (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01; Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>b) levels to those of the CORT-treated group, similar to what was observed under CORT treatment alone. These findings indicate that the phosphorylation of TH and CREB is mediated by PKA through OXTR signaling transduction in response to stress-induced DA dysfunction.</p><p id="Par26">
<fig id="Fig6"><label>Fig. 6</label><caption><p>Western blot analysis of tTH (<bold>a</bold>), pTH (<bold>b</bold>), pTH/tTH (<bold>c</bold>) and pCREB (<bold>d</bold>) in control, CORT-treated, OXT-pretreated, and H89&#x02009;+&#x02009;OXT-pretreated SH-SY5Y cells (<italic>n</italic>&#x02009;=&#x02009;4 per group). The intensity of the product bands was normalized against that of the respective internal controls. Bar graph displays the corresponding quantitative results. The data are expressed as a percentage of the control. The values represent the means&#x02009;&#x000b1;&#x02009;SEM. Statistical significance is denoted as *<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05, **<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.01, *** <italic>p&#x02009;&#x0003c;</italic>&#x02009;0.001</p></caption><graphic xlink:href="11064_2024_4294_Fig6_HTML" id="d33e644"/></fig>
</p></sec></sec><sec id="Sec12" sec-type="discussion"><title>Discussion</title><p id="Par27">Dopamine dysfunction plays a significant role in various disorders characterized by social impairment, including ADHD, ASD, schizophrenia, anxiety, and depressive disorders [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Furthermore, stress can negatively impact DA function, affecting mood and social cognition. A common thread across these disorders is the impact of altered DA signaling on social cognition, motivation, and behavior under stress conditions [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Previous studies utilizing various stress induction models have also shown alterations in TH activity following stress. These stress models, which include social defeat, immobilization, foot shock, and hypoglycemia induction, decrease TH phosphorylation in the brain [<xref ref-type="bibr" rid="CR44">44</xref>&#x02013;<xref ref-type="bibr" rid="CR47">47</xref>]. The phosphorylation of the TH enzyme serves as a key indicator of dopaminergic function. Decreased TH phosphorylation can lead to DA synthesis failure and DA hypofunction [<xref ref-type="bibr" rid="CR48">48</xref>]. In addition, the TH gene has been associated with the pathogenesis of ASD and ADHD, particularly concerning executive function performance under stressful conditions [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par28">Transcription of the TH gene is CREB dependent [<xref ref-type="bibr" rid="CR49">49</xref>]. CREB is a critical transcription factor implicated in neural plasticity, underpinning memory and learning. The phosphorylation of CREB at Ser133 is essential for the induction of TH gene transcription via CREB/AP-1 family members in PC12 cells [<xref ref-type="bibr" rid="CR50">50</xref>]. In this study, the finding that CORT decreases pCREB aligns with the findings of previous studies showing that chronic stress reduces CREB phosphorylation, leading to decreased neural plasticity in limbic brain areas associated with mood disorders [<xref ref-type="bibr" rid="CR51">51</xref>]. Additionally, severe stress adversely affects CREB and BDNF in the developing hippocampus and other brain regions, further impacting neural plasticity [<xref ref-type="bibr" rid="CR52">52</xref>]. Our results indicate that CORT might disrupt DA synthesis and induce DA dysfunction by reducing pCREB and pTH levels in SH-SY5Y cells. These findings highlight that DA dysfunction might be a key mechanism underlying the effects of stress on mood and social dysfunction.</p><p id="Par29">Research indicates that OXT reduces stress responses in brain regions involved in regulating HPA axis activity, such as the paraventricular nucleus (PVN), ventrolateral septum (LSV), and dorsal hippocampus [<xref ref-type="bibr" rid="CR53">53</xref>]. Moreover, OXT has been shown to improve social cognition in older adults [<xref ref-type="bibr" rid="CR54">54</xref>] and reduce negative behavioral symptoms in patients with frontotemporal dementia [<xref ref-type="bibr" rid="CR55">55</xref>]. Additionally, OXT treatment can reverse anxiety and social dysfunction in offspring exposed to prenatal stress [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Importantly, OXT influences social behavior by modulating dopaminergic neurons, particularly in the VTA [<xref ref-type="bibr" rid="CR58">58</xref>&#x02013;<xref ref-type="bibr" rid="CR60">60</xref>]. This interaction enhances the salience of social stimuli, whether it is positive or negative. These findings underscore the importance of OXT-DA interactions in both normal and pathological social behaviors, providing insights into potential therapeutic targets for social deficits. These lines of evidence suggest that OXT plays a vital role in mitigating the adverse effects of stress; however, despite its effectiveness in reducing stress-induced anxiety and improving social behaviors, the specific mechanisms by which OXT counteracts dopamine dysfunction under stress are not yet fully understood.</p><p id="Par30">In the present study, we demonstrated that OXT pretreatment significantly reduces the effects of CORT by increasing PKAc-&#x003b1; levels and enhancing CREB phosphorylation at Ser 133. PKA is a holoenzyme that remains inactive under basal conditions. However, when activated, its active form, PKAc-&#x003b1;, transfers phosphate groups to Ser/Thr residues of target proteins, including CREB [<xref ref-type="bibr" rid="CR61">61</xref>]. In PC12 cells, CREB phosphorylation facilitates TH gene expression through CREB/AP-1 family members [<xref ref-type="bibr" rid="CR50">50</xref>], and OXT treatment increases TH protein levels in the adrenal medulla of socially isolated rats without affecting TH mRNA levels [<xref ref-type="bibr" rid="CR62">62</xref>]. Previous research has shown that OXT can prevent cell death from metabolic stress by enhancing the MAPK/ERK-CREB signaling pathway in pancreatic beta cells [<xref ref-type="bibr" rid="CR63">63</xref>]. Additionally, OXT promotes long-term synaptic plasticity and memory via MAPK cascade activation and CREB phosphorylation in the hippocampus, which are crucial for offspring development and survival [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. Taken together, these findings suggest that OXT may modulate dopaminergic function in SH-SY5Y cells by influencing PKAc-&#x003b1;, pCREB, and pTH levels to counteract the adverse effects of CORT. Furthermore, the protective effects of OXT were abolished by pretreatment with H89, a potent and selective PKA inhibitor [<xref ref-type="bibr" rid="CR66">66</xref>], indicating that the protective effects of OXT operate through the PKA/CREB pathway.</p><p id="Par31">Finally, the finding that atosiban reversed the protective effects of OXT against CORT toxicity suggested that OXT exerts its protective effect through OXT receptors, emphasizing its role in mitigating CORT toxicity. Indeed, the expression of OXT receptors in SH-SY5Y cells has been documented in various studies. For instance, one study demonstrated that activation of OXT receptors in these cells can modulate the expression of synaptic adhesion molecules, confirming the presence of functional receptors [<xref ref-type="bibr" rid="CR67">67</xref>]. Additionally, oxytocin affects neurite outgrowth and cytoskeletal protein expression, further supporting the presence of OXT receptors in SH-SY5Y cells [<xref ref-type="bibr" rid="CR68">68</xref>]. These findings collectively support the notion that SH-SY5Y cells express oxytocin receptors and respond to oxytocin signaling.</p><p id="Par32">Our findings suggest a potential role for OXT in counteracting stress-induced DA dysfunction through the PKA/CREB signaling pathway (see Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). By showing that OXT increases PKAc-&#x003b1; levels and enhances CREB phosphorylation, with these effects blocked by atosiban and the PKA inhibitor H89, our study highlights OXT&#x02019;s potential to influence dopaminergic signaling. While our results imply that OXT could mitigate stress-related DA dysregulation, we recognize that these findings provide indirect rather than direct evidence of its role in dopaminergic regulation. Future research should include functional assays to clarify this mechanistic link. Nonetheless, the ability of OXT to modulate DAergic activity and potentially enhance stress resilience suggests promising therapeutic strategies for stress-related disorders, where DA dysfunction is a key factor. This insight advances our understanding of stress neurobiology and may inform novel approaches for improving mental health and cognitive function in stress-prone conditions.</p><sec id="Sec13"><title>Limitations</title><p id="Par33">There are some limitations to this study that should be considered. First, in this study, the undifferentiated SH-SY5Y cells were used as a model system to study dopaminergic function. Although these cells express certain dopaminergic markers, they do not fully replicate the morphology and functionality of mature dopaminergic neurons due to their tumor cell origin. Utilizing differentiation protocols could improve the relevance of SH-SY5Y cells as a model for studying dopaminergic mechanisms. Consequently, future studies should incorporate specific differentiation protocols or use complementary models, such as primary neurons or animal models, to achieve a more comprehensive understanding of oxytocin&#x02019;s effects on dopaminergic regulation.</p><p id="Par34">Another limitation of this study is its reliance on Western blotting as the primary method for assessing protein expression and phosphorylation levels. While Western blotting provides valuable information about protein dynamics, it has limitations in sensitivity and quantification. Incorporating additional techniques, such as ELISA or mass spectrometry, could yield more comprehensive and precise data, allowing for better validation of our findings and potentially uncovering subtler variations in protein expression and modifications. Future studies that integrate these complementary methods would strengthen the robustness and accuracy of the data, advancing our understanding of oxytocin&#x02019;s role in dopaminergic regulation.</p><p id="Par35">
<fig id="Fig7"><label>Fig. 7</label><caption><p>Proposed mechanism underlying the neuroprotective effects of OXT against CORT-induced dopamine dysfunction in SH-SY5Y cells. OXT binds to its receptor, resulting in augmented stimulation of cAMP, which serves as an activator of PKA. Subsequently, PKA phosphorylates TH at Ser40 and CREB at Ser133. Phosphorylated CREB can bind to downstream coactivators to orchestrate the transcriptional activity of its target, including the TH gene. This regulatory process contributes to the protective effects of OXT against CORT-induced toxicity, thereby conferring neuroprotection. (Created with BioRender.com/Mahidol University)</p></caption><graphic xlink:href="11064_2024_4294_Fig7_HTML" id="d33e780"/></fig>
</p></sec></sec><sec id="Sec14" sec-type="conclusion"><title>Conclusion</title><p id="Par36">In conclusion, our study provides preliminary evidence that OXT may plays a role in mitigating the adverse effects of stress on DA function, potentially through the PKA/CREB signaling pathway. Although these findings suggest that OXT could be a promising therapeutic intervention for stress-related disorders, further research using differentiated cellular models and complementary techniques is necessary to confirm and expand upon these results. Our study contributes to the understanding of the neurobiological mechanisms underlying stress resilience and suggests potential pathways for developing targeted treatments that leverage the neuroprotective properties of OXT to address disorders characterized by DA dysregulation and impaired stress responses.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to thank Assoc. Prof. Wipawan Thangnipon for her kindness in providing the human neuroblastoma SH-SY5Y cell lines used in this study.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>S.C.; experimental design, investigation, formal analysis, prepared all figures, and drafted the original manuscript. T.S.; experimental design and methodology. C.N.; experimental design, methodology, and supervision. N.C.; conceptualization, experimental design, supervision, validation, data interpretation, critical review, prepared all figures, and final manuscript editing. All authors reviewed the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by Mahidol University</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing Interests</title><p id="Par37">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Hinds</surname><given-names>JA</given-names></name><name><surname>Sanchez</surname><given-names>ER</given-names></name></person-group><article-title>The role of the hypothalamus&#x02013;pituitary&#x02013;adrenal (HPA) Axis in Test-Induced anxiety: assessments, physiological responses, and Molecular Details</article-title><source>Stresses</source><year>2022</year><volume>2</volume><fpage>146</fpage><lpage>155</lpage></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Hinds JA, Sanchez ER (2022) The role of the hypothalamus&#x02013;pituitary&#x02013;adrenal (HPA) Axis in Test-Induced anxiety: assessments, physiological responses, and Molecular Details. Stresses 2:146&#x02013;155</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>de Kloet</surname><given-names>ER</given-names></name><name><surname>Joels</surname><given-names>M</given-names></name><name><surname>Holsboer</surname><given-names>F</given-names></name></person-group><article-title>Stress and the brain: from adaptation to disease</article-title><source>Nat Rev Neurosci</source><year>2005</year><volume>6</volume><fpage>463</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">15891777</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463&#x02013;475<pub-id pub-id-type="pmid">15891777</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Karin</surname><given-names>O</given-names></name><name><surname>Raz</surname><given-names>M</given-names></name><name><surname>Tendler</surname><given-names>A</given-names></name><name><surname>Bar</surname><given-names>A</given-names></name><name><surname>Korem Kohanim</surname><given-names>Y</given-names></name><name><surname>Milo</surname><given-names>T</given-names></name><name><surname>Alon</surname><given-names>U</given-names></name></person-group><article-title>A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks</article-title><source>Mol Syst Biol</source><year>2020</year><volume>16</volume><fpage>e9510</fpage><pub-id pub-id-type="pmid">32672906</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Karin O, Raz M, Tendler A, Bar A, Korem Kohanim Y, Milo T, Alon U (2020) A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks. Mol Syst Biol 16:e9510<pub-id pub-id-type="pmid">32672906</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>T</given-names></name><name><surname>Conley</surname><given-names>RE</given-names></name><name><surname>Mittal</surname><given-names>VA</given-names></name></person-group><article-title>Chronic stress, structural exposures and neurobiological mechanisms: a stimulation, discrepancy and deprivation model of psychosis</article-title><source>Int Rev Neurobiol</source><year>2020</year><volume>152</volume><fpage>41</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">32451000</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Vargas T, Conley RE, Mittal VA (2020) Chronic stress, structural exposures and neurobiological mechanisms: a stimulation, discrepancy and deprivation model of psychosis. Int Rev Neurobiol 152:41&#x02013;69<pub-id pub-id-type="pmid">32451000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Bowirrat</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>TJH</given-names></name><name><surname>Oscar-Berman</surname><given-names>M</given-names></name><name><surname>Madigan</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>AL</given-names></name><name><surname>Bailey</surname><given-names>JA</given-names></name><name><surname>Braverman</surname><given-names>ER</given-names></name><name><surname>Kerner</surname><given-names>M</given-names></name><name><surname>Giordano</surname><given-names>J</given-names></name><name><surname>Morse</surname><given-names>S</given-names></name><name><surname>Downs</surname><given-names>BW</given-names></name><name><surname>Waite</surname><given-names>RL</given-names></name><name><surname>Fornari</surname><given-names>F</given-names></name><name><surname>Armaly</surname><given-names>Z</given-names></name><name><surname>Blum</surname><given-names>K</given-names></name></person-group><article-title>Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?</article-title><source>Mol Neurobiol</source><year>2012</year><volume>45</volume><fpage>298</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">22371275</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Bowirrat A, Chen TJH, Oscar-Berman M, Madigan M, Chen AL, Bailey JA, Braverman ER, Kerner M, Giordano J, Morse S, Downs BW, Waite RL, Fornari F, Armaly Z, Blum K (2012) Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment? Mol Neurobiol 45:298&#x02013;313<pub-id pub-id-type="pmid">22371275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Ardenne</surname><given-names>K</given-names></name><name><surname>Eshel</surname><given-names>N</given-names></name><name><surname>Luka</surname><given-names>J</given-names></name><name><surname>Lenartowicz</surname><given-names>A</given-names></name><name><surname>Nystrom</surname><given-names>LE</given-names></name><name><surname>Cohen</surname><given-names>JD</given-names></name></person-group><article-title>Role of prefrontal cortex and the midbrain dopamine system in working memory updating</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>19900</fpage><lpage>19909</lpage><pub-id pub-id-type="pmid">23086162</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">D&#x02019;Ardenne K, Eshel N, Luka J, Lenartowicz A, Nystrom LE, Cohen JD (2012) Role of prefrontal cortex and the midbrain dopamine system in working memory updating. Proc Natl Acad Sci U S A 109:19900&#x02013;19909<pub-id pub-id-type="pmid">23086162</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname><given-names>T</given-names></name><name><surname>Nieder</surname><given-names>A</given-names></name></person-group><article-title>Dopamine and Cognitive Control in Prefrontal Cortex</article-title><source>Trends Cogn Sci</source><year>2019</year><volume>23</volume><fpage>213</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">30711326</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Ott T, Nieder A (2019) Dopamine and Cognitive Control in Prefrontal Cortex. Trends Cogn Sci 23:213&#x02013;234<pub-id pub-id-type="pmid">30711326</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Puig MV, Rose J, Schmidt R, Freund N (2014) Dopamine modulation of learning and memory in the prefrontal cortex: insights from studies in primates, rodents, and birds. Frontiers in Neural Circuits 8</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Qin</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name></person-group><article-title>The aversion function of the limbic dopaminergic neurons and their roles in Functional Neurological disorders</article-title><source>Front Cell Dev Biol</source><year>2021</year><volume>9</volume><fpage>713762</fpage><pub-id pub-id-type="pmid">34616730</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">He Z, Jiang Y, Gu S, Wu D, Qin D, Feng G, Ma X, Huang JH, Wang F (2021) The aversion function of the limbic dopaminergic neurons and their roles in Functional Neurological disorders. Front Cell Dev Biol 9:713762<pub-id pub-id-type="pmid">34616730</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Ju&#x000e1;rez Olgu&#x000ed;n H, Calder&#x000f3;n Guzm&#x000e1;n D, Hern&#x000e1;ndez Garc&#x000ed;a E, Barrag&#x000e1;n Mej&#x000ed;a G (2016) The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress. Oxid Med Cell Longev 2016:9730467</mixed-citation></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>C-B</given-names></name><name><surname>Baek</surname><given-names>S-S</given-names></name></person-group><article-title>Effect of treadmill exercise on social interaction and tyrosine hydroxylase expression in the attention-deficit/ hyperactivity disorder rats</article-title><source>J Exerc Rehabilitation</source><year>2014</year><volume>10</volume><fpage>252</fpage><lpage>257</lpage></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Baek DJ, Lee C-B, Baek S-S (2014) Effect of treadmill exercise on social interaction and tyrosine hydroxylase expression in the attention-deficit/ hyperactivity disorder rats. J Exerc Rehabilitation 10:252&#x02013;257</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminer</surname><given-names>J</given-names></name><name><surname>Espinoza</surname><given-names>D</given-names></name><name><surname>Bhimani</surname><given-names>S</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koos</surname><given-names>T</given-names></name><name><surname>Shiflett</surname><given-names>MW</given-names></name></person-group><article-title>Loss of striatal tyrosine-hydroxylase interneurons impairs instrumental goal-directed behavior</article-title><source>Eur J Neurosci</source><year>2019</year><volume>50</volume><fpage>2653</fpage><lpage>2662</lpage><pub-id pub-id-type="pmid">30941837</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kaminer J, Espinoza D, Bhimani S, Tepper JM, Koos T, Shiflett MW (2019) Loss of striatal tyrosine-hydroxylase interneurons impairs instrumental goal-directed behavior. Eur J Neurosci 50:2653&#x02013;2662<pub-id pub-id-type="pmid">30941837</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Trainor</surname><given-names>BC</given-names></name></person-group><article-title>Stress responses and the mesolimbic dopamine system: social contexts and sex differences</article-title><source>Horm Behav</source><year>2011</year><volume>60</volume><fpage>457</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">21907202</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Trainor BC (2011) Stress responses and the mesolimbic dopamine system: social contexts and sex differences. Horm Behav 60:457&#x02013;469<pub-id pub-id-type="pmid">21907202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Ironside</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Kang</surname><given-names>MS</given-names></name><name><surname>Pizzagalli</surname><given-names>DA</given-names></name></person-group><article-title>Brain mechanisms mediating effects of stress on reward sensitivity</article-title><source>Curr Opin Behav Sci</source><year>2018</year><volume>22</volume><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">30349872</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ironside M, Kumar P, Kang MS, Pizzagalli DA (2018) Brain mechanisms mediating effects of stress on reward sensitivity. Curr Opin Behav Sci 22:106&#x02013;113<pub-id pub-id-type="pmid">30349872</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Lamontagne</surname><given-names>SJ</given-names></name><name><surname>Wash</surname><given-names>SIJ</given-names></name><name><surname>Irwin</surname><given-names>SH</given-names></name><name><surname>Zucconi</surname><given-names>KE</given-names></name><name><surname>Olmstead</surname><given-names>MC</given-names></name></person-group><article-title>Effects of dopamine modulation on chronic stress-induced deficits in reward learning</article-title><source>Cogn Affect Behav Neurosci</source><year>2022</year><volume>22</volume><fpage>736</fpage><lpage>753</lpage><pub-id pub-id-type="pmid">35396630</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Lamontagne SJ, Wash SIJ, Irwin SH, Zucconi KE, Olmstead MC (2022) Effects of dopamine modulation on chronic stress-induced deficits in reward learning. Cogn Affect Behav Neurosci 22:736&#x02013;753<pub-id pub-id-type="pmid">35396630</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Bloomfield MA, McCutcheon RA, Kempton M, Freeman TP, Howes O (2019) The effects of psychosocial stress on dopaminergic function and the acute stress response. Elife 8</mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Quessy</surname><given-names>F</given-names></name><name><surname>Bittar</surname><given-names>T</given-names></name><name><surname>Blanchette</surname><given-names>LJ</given-names></name><name><surname>L&#x000e9;vesque</surname><given-names>M</given-names></name><name><surname>Labont&#x000e9;</surname><given-names>B</given-names></name></person-group><article-title>Stress-induced alterations of mesocortical and mesolimbic dopaminergic pathways</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><fpage>11000</fpage><pub-id pub-id-type="pmid">34040100</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Quessy F, Bittar T, Blanchette LJ, L&#x000e9;vesque M, Labont&#x000e9; B (2021) Stress-induced alterations of mesocortical and mesolimbic dopaminergic pathways. Sci Rep 11:11000<pub-id pub-id-type="pmid">34040100</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Carcea</surname><given-names>I</given-names></name><name><surname>Caraballo</surname><given-names>NL</given-names></name><name><surname>Marlin</surname><given-names>BJ</given-names></name><name><surname>Ooyama</surname><given-names>R</given-names></name><name><surname>Riceberg</surname><given-names>JS</given-names></name><name><surname>Mendoza Navarro</surname><given-names>JM</given-names></name><name><surname>Opendak</surname><given-names>M</given-names></name><name><surname>Diaz</surname><given-names>VE</given-names></name><name><surname>Schuster</surname><given-names>L</given-names></name><name><surname>Alvarado Torres</surname><given-names>MI</given-names></name><name><surname>Lethin</surname><given-names>H</given-names></name><name><surname>Ramos</surname><given-names>D</given-names></name><name><surname>Minder</surname><given-names>J</given-names></name><name><surname>Mendoza</surname><given-names>SL</given-names></name><name><surname>Bair-Marshall</surname><given-names>CJ</given-names></name><name><surname>Samadjopoulos</surname><given-names>GH</given-names></name><name><surname>Hidema</surname><given-names>S</given-names></name><name><surname>Falkner</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Mar</surname><given-names>A</given-names></name><name><surname>Wadghiri</surname><given-names>YZ</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Kikusui</surname><given-names>T</given-names></name><name><surname>Mogi</surname><given-names>K</given-names></name><name><surname>Sullivan</surname><given-names>RM</given-names></name><name><surname>Froemke</surname><given-names>RC</given-names></name></person-group><article-title>Oxytocin neurons enable social transmission of maternal behaviour</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">34381215</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Carcea I, Caraballo NL, Marlin BJ, Ooyama R, Riceberg JS, Mendoza Navarro JM, Opendak M, Diaz VE, Schuster L, Alvarado Torres MI, Lethin H, Ramos D, Minder J, Mendoza SL, Bair-Marshall CJ, Samadjopoulos GH, Hidema S, Falkner A, Lin D, Mar A, Wadghiri YZ, Nishimori K, Kikusui T, Mogi K, Sullivan RM, Froemke RC (2021) Oxytocin neurons enable social transmission of maternal behaviour. Nature 596:553&#x02013;557<pub-id pub-id-type="pmid">34381215</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Grinevich</surname><given-names>V</given-names></name><name><surname>Knobloch-Bollmann</surname><given-names>HS</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Busnelli</surname><given-names>M</given-names></name><name><surname>Chini</surname><given-names>B</given-names></name></person-group><article-title>Assembling the puzzle: pathways of Oxytocin Signaling in the brain</article-title><source>Biol Psychiatry</source><year>2016</year><volume>79</volume><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">26001309</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Grinevich V, Knobloch-Bollmann HS, Eliava M, Busnelli M, Chini B (2016) Assembling the puzzle: pathways of Oxytocin Signaling in the brain. Biol Psychiatry 79:155&#x02013;164<pub-id pub-id-type="pmid">26001309</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>TF</given-names></name><name><surname>Hou</surname><given-names>G</given-names></name></person-group><article-title>Commentary: Oxytocin enables maternal behavior by balancing cortical inhibition</article-title><source>Front Behav Neurosci</source><year>2015</year><volume>9</volume><fpage>311</fpage><pub-id pub-id-type="pmid">26635561</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Yuan TF, Hou G (2015) Commentary: Oxytocin enables maternal behavior by balancing cortical inhibition. Front Behav Neurosci 9:311<pub-id pub-id-type="pmid">26635561</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Gulliver</surname><given-names>D</given-names></name><name><surname>Werry</surname><given-names>E</given-names></name><name><surname>Reekie</surname><given-names>TA</given-names></name><name><surname>Katte</surname><given-names>TA</given-names></name><name><surname>Jorgensen</surname><given-names>W</given-names></name><name><surname>Kassiou</surname><given-names>M</given-names></name></person-group><article-title>Targeting the Oxytocin System: New Pharmacotherapeutic approaches</article-title><source>Trends Pharmacol Sci</source><year>2019</year><volume>40</volume><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">30509888</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Gulliver D, Werry E, Reekie TA, Katte TA, Jorgensen W, Kassiou M (2019) Targeting the Oxytocin System: New Pharmacotherapeutic approaches. Trends Pharmacol Sci 40:22&#x02013;37<pub-id pub-id-type="pmid">30509888</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Bartholomeusz</surname><given-names>CF</given-names></name><name><surname>Ganella</surname><given-names>EP</given-names></name><name><surname>Labuschagne</surname><given-names>I</given-names></name><name><surname>Bousman</surname><given-names>C</given-names></name><name><surname>Pantelis</surname><given-names>C</given-names></name></person-group><article-title>Effects of oxytocin and genetic variants on brain and behaviour: implications for treatment in schizophrenia</article-title><source>Schizophr Res</source><year>2015</year><volume>168</volume><fpage>614</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">26123171</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Bartholomeusz CF, Ganella EP, Labuschagne I, Bousman C, Pantelis C (2015) Effects of oxytocin and genetic variants on brain and behaviour: implications for treatment in schizophrenia. Schizophr Res 168:614&#x02013;627<pub-id pub-id-type="pmid">26123171</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>CS</given-names></name><name><surname>Kenkel</surname><given-names>WM</given-names></name><name><surname>MacLean</surname><given-names>EL</given-names></name><name><surname>Wilson</surname><given-names>SR</given-names></name><name><surname>Perkeybile</surname><given-names>AM</given-names></name><name><surname>Yee</surname><given-names>JR</given-names></name><name><surname>Ferris</surname><given-names>CF</given-names></name><name><surname>Nazarloo</surname><given-names>HP</given-names></name><name><surname>Porges</surname><given-names>SW</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Connelly</surname><given-names>JJ</given-names></name><name><surname>Kingsbury</surname><given-names>MA</given-names></name></person-group><article-title>Is Oxytocin Nature&#x02019;s Medicine?</article-title><source>Pharmacol Rev</source><year>2020</year><volume>72</volume><fpage>829</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">32912963</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Carter CS, Kenkel WM, MacLean EL, Wilson SR, Perkeybile AM, Yee JR, Ferris CF, Nazarloo HP, Porges SW, Davis JM, Connelly JJ, Kingsbury MA (2020) Is Oxytocin Nature&#x02019;s Medicine? Pharmacol Rev 72:829&#x02013;861<pub-id pub-id-type="pmid">32912963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Barrera</surname><given-names>I</given-names></name><name><surname>Brothers</surname><given-names>S</given-names></name><name><surname>Ring</surname><given-names>R</given-names></name><name><surname>Wahlestedt</surname><given-names>C</given-names></name></person-group><article-title>Oxytocin and social functioning</article-title><source>Dialogues Clin Neurosci</source><year>2017</year><volume>19</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">28867943</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Jones C, Barrera I, Brothers S, Ring R, Wahlestedt C (2017) Oxytocin and social functioning. Dialogues Clin Neurosci 19:193&#x02013;201<pub-id pub-id-type="pmid">28867943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Olff</surname><given-names>M</given-names></name><name><surname>Frijling</surname><given-names>JL</given-names></name><name><surname>Kubzansky</surname><given-names>LD</given-names></name><name><surname>Bradley</surname><given-names>B</given-names></name><name><surname>Ellenbogen</surname><given-names>MA</given-names></name><name><surname>Cardoso</surname><given-names>C</given-names></name><name><surname>Bartz</surname><given-names>JA</given-names></name><name><surname>Yee</surname><given-names>JR</given-names></name><name><surname>van Zuiden</surname><given-names>M</given-names></name></person-group><article-title>The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences</article-title><source>Psychoneuroendocrinology</source><year>2013</year><volume>38</volume><fpage>1883</fpage><lpage>1894</lpage><pub-id pub-id-type="pmid">23856187</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Olff M, Frijling JL, Kubzansky LD, Bradley B, Ellenbogen MA, Cardoso C, Bartz JA, Yee JR, van Zuiden M (2013) The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology 38:1883&#x02013;1894<pub-id pub-id-type="pmid">23856187</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Takahashi T (2021) Sensory stimulation of Oxytocin Release is Associated with stress management and maternal care. Frontiers in Psychology 11</mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Onaka</surname><given-names>T</given-names></name><name><surname>Takayanagi</surname><given-names>Y</given-names></name></person-group><article-title>Role of oxytocin in the control of stress and food intake</article-title><source>J Neuroendocrinol</source><year>2019</year><volume>31</volume><fpage>e12700</fpage><pub-id pub-id-type="pmid">30786104</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Onaka T, Takayanagi Y (2019) Role of oxytocin in the control of stress and food intake. J Neuroendocrinol 31:e12700<pub-id pub-id-type="pmid">30786104</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Takayanagi</surname><given-names>Y</given-names></name><name><surname>Onaka</surname><given-names>T</given-names></name></person-group><article-title>Roles of oxytocin in stress responses, Allostasis and Resilience</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><fpage>150</fpage></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Takayanagi Y, Onaka T (2022) Roles of oxytocin in stress responses, Allostasis and Resilience. Int J Mol Sci 23:150</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Charlet</surname><given-names>A</given-names></name><name><surname>Grinevich</surname><given-names>V</given-names></name></person-group><article-title>Oxytocin mobilizes midbrain dopamine toward sociality</article-title><source>Neuron</source><year>2017</year><volume>95</volume><fpage>235</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">28728017</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Charlet A, Grinevich V (2017) Oxytocin mobilizes midbrain dopamine toward sociality. Neuron 95:235&#x02013;237<pub-id pub-id-type="pmid">28728017</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Xiao L, Priest MF, Kozorovitskiy Y (2018) Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons. Elife 7</mixed-citation></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Ioghen</surname><given-names>OC</given-names></name><name><surname>Ceafalan</surname><given-names>LC</given-names></name><name><surname>Popescu</surname><given-names>BO</given-names></name></person-group><article-title>SH-SY5Y Cell Line in Vitro models for Parkinson Disease Research-Old Practice for New trends</article-title><source>J Integr Neurosci</source><year>2023</year><volume>22</volume><fpage>20</fpage><pub-id pub-id-type="pmid">36722247</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Ioghen OC, Ceafalan LC, Popescu BO (2023) SH-SY5Y Cell Line in Vitro models for Parkinson Disease Research-Old Practice for New trends. J Integr Neurosci 22:20<pub-id pub-id-type="pmid">36722247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Kovalevich</surname><given-names>J</given-names></name><name><surname>Langford</surname><given-names>D</given-names></name></person-group><article-title>Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology</article-title><source>Methods Mol Biol</source><year>2013</year><volume>1078</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">23975817</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kovalevich J, Langford D (2013) Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 1078:9&#x02013;21<pub-id pub-id-type="pmid">23975817</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Xicoy</surname><given-names>H</given-names></name><name><surname>Wieringa</surname><given-names>B</given-names></name><name><surname>Martens</surname><given-names>GJM</given-names></name></person-group><article-title>The SH-SY5Y cell line in Parkinson&#x02019;s disease research: a systematic review</article-title><source>Mol Neurodegeneration</source><year>2017</year><volume>12</volume><fpage>10</fpage></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Xicoy H, Wieringa B, Martens GJM (2017) The SH-SY5Y cell line in Parkinson&#x02019;s disease research: a systematic review. Mol Neurodegeneration 12:10</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>KM</given-names></name><name><surname>Frank</surname><given-names>DA</given-names></name></person-group><article-title>CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy</article-title><source>Clin Cancer Res</source><year>2009</year><volume>15</volume><fpage>2583</fpage><lpage>2587</lpage><pub-id pub-id-type="pmid">19351775</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Sakamoto KM, Frank DA (2009) CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res 15:2583&#x02013;2587<pub-id pub-id-type="pmid">19351775</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosethorne</surname><given-names>EM</given-names></name><name><surname>Nahorski</surname><given-names>SR</given-names></name><name><surname>Challiss</surname><given-names>RA</given-names></name></person-group><article-title>Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells</article-title><source>Biochem Pharmacol</source><year>2008</year><volume>75</volume><fpage>942</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">18036509</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Rosethorne EM, Nahorski SR, Challiss RA (2008) Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells. Biochem Pharmacol 75:942&#x02013;955<pub-id pub-id-type="pmid">18036509</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Mairuae</surname><given-names>N</given-names></name><name><surname>Connor</surname><given-names>JR</given-names></name><name><surname>Buranrat</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name></person-group><article-title>Oroxylum Indicum (L.) extract protects human neuroblastoma SH&#x02013;SY5Y cells against beta&#x02013;amyloid&#x02013;induced cell injury</article-title><source>Mol Med Rep</source><year>2019</year><volume>20</volume><fpage>1933</fpage><lpage>1942</lpage><pub-id pub-id-type="pmid">31257498</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Mairuae N, Connor JR, Buranrat B, Lee SY (2019) Oroxylum Indicum (L.) extract protects human neuroblastoma SH&#x02013;SY5Y cells against beta&#x02013;amyloid&#x02013;induced cell injury. Mol Med Rep 20:1933&#x02013;1942<pub-id pub-id-type="pmid">31257498</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>T</given-names></name></person-group><article-title>Neuroprotective effect of Arctigenin via Upregulation of P-CREB in mouse primary neurons and Human SH-SY5Y Neuroblastoma cells</article-title><source>Int J Mol Sci</source><year>2013</year><volume>14</volume><fpage>18657</fpage><lpage>18669</lpage><pub-id pub-id-type="pmid">24025424</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Zhang N, Wen Q, Ren L, Liang W, Xia Y, Zhang X, Zhao D, Sun D, Hu Y, Hao H, Yan Y, Zhang G, Yang J, Kang T (2013) Neuroprotective effect of Arctigenin via Upregulation of P-CREB in mouse primary neurons and Human SH-SY5Y Neuroblastoma cells. Int J Mol Sci 14:18657&#x02013;18669<pub-id pub-id-type="pmid">24025424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Budni</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>A</given-names></name><name><surname>Molz</surname><given-names>S</given-names></name><name><surname>Martin-de-Saavedra</surname><given-names>MD</given-names></name><name><surname>Egea</surname><given-names>J</given-names></name><name><surname>Del Barrio</surname><given-names>L</given-names></name><name><surname>Tasca</surname><given-names>CI</given-names></name><name><surname>Rodrigues</surname><given-names>AL</given-names></name><name><surname>Lopez</surname><given-names>MG</given-names></name></person-group><article-title>Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid</article-title><source>Neuroscience</source><year>2011</year><volume>190</volume><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">21640799</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Budni J, Romero A, Molz S, Martin-de-Saavedra MD, Egea J, Del Barrio L, Tasca CI, Rodrigues AL, Lopez MG (2011) Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid. Neuroscience 190:346&#x02013;353<pub-id pub-id-type="pmid">21640799</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Chilumuri A, Milton NG (2013) The Role of Neurotransmitters in Protection against Amyloid- beta Toxicity by KiSS-1 Overexpression in SH-SY5Y Neurons. ISRN Neurosci 2013:253210</mixed-citation></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>MP</given-names></name><name><surname>Martin-de-Saavedra</surname><given-names>MD</given-names></name><name><surname>Romero</surname><given-names>A</given-names></name><name><surname>Parada</surname><given-names>E</given-names></name><name><surname>Egea</surname><given-names>J</given-names></name><name><surname>Del Barrio</surname><given-names>L</given-names></name><name><surname>Rodrigues</surname><given-names>AL</given-names></name><name><surname>Lopez</surname><given-names>MG</given-names></name></person-group><article-title>Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: involvement of intracellular signaling pathways</article-title><source>Neuroscience</source><year>2013</year><volume>238</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">23485810</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Cunha MP, Martin-de-Saavedra MD, Romero A, Parada E, Egea J, Del Barrio L, Rodrigues AL, Lopez MG (2013) Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: involvement of intracellular signaling pathways. Neuroscience 238:185&#x02013;194<pub-id pub-id-type="pmid">23485810</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Blum</surname><given-names>K</given-names></name><name><surname>Oscar-Berman</surname><given-names>M</given-names></name><name><surname>Braverman</surname><given-names>ER</given-names></name></person-group><article-title>Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?</article-title><source>Postgrad Med</source><year>2014</year><volume>126</volume><fpage>153</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">24393762</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Gold MS, Blum K, Oscar-Berman M, Braverman ER (2014) Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med 126:153&#x02013;177<pub-id pub-id-type="pmid">24393762</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Kosillo</surname><given-names>P</given-names></name><name><surname>Bateup</surname><given-names>HS</given-names></name></person-group><article-title>Dopaminergic dysregulation in Syndromic Autism Spectrum disorders: insights from genetic mouse models</article-title><source>Front Neural Circuits</source><year>2021</year><volume>15</volume><fpage>700968</fpage><pub-id pub-id-type="pmid">34366796</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Kosillo P, Bateup HS (2021) Dopaminergic dysregulation in Syndromic Autism Spectrum disorders: insights from genetic mouse models. Front Neural Circuits 15:700968<pub-id pub-id-type="pmid">34366796</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Baik</surname><given-names>J-H</given-names></name></person-group><article-title>Stress and the dopaminergic reward system</article-title><source>Exp Mol Med</source><year>2020</year><volume>52</volume><fpage>1879</fpage><lpage>1890</lpage><pub-id pub-id-type="pmid">33257725</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Baik J-H (2020) Stress and the dopaminergic reward system. Exp Mol Med 52:1879&#x02013;1890<pub-id pub-id-type="pmid">33257725</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Bobrovskaya</surname><given-names>L</given-names></name><name><surname>Damanhuri</surname><given-names>HA</given-names></name><name><surname>Ong</surname><given-names>LK</given-names></name><name><surname>Schneider</surname><given-names>JJ</given-names></name><name><surname>Dickson</surname><given-names>PW</given-names></name><name><surname>Dunkley</surname><given-names>PR</given-names></name><name><surname>Goodchild</surname><given-names>AK</given-names></name></person-group><article-title>Signal transduction pathways and tyrosine hydroxylase regulation in the adrenal medulla following glucoprivation: an in vivo analysis</article-title><source>Neurochem Int</source><year>2010</year><volume>57</volume><fpage>162</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">20493917</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Bobrovskaya L, Damanhuri HA, Ong LK, Schneider JJ, Dickson PW, Dunkley PR, Goodchild AK (2010) Signal transduction pathways and tyrosine hydroxylase regulation in the adrenal medulla following glucoprivation: an in vivo analysis. Neurochem Int 57:162&#x02013;167<pub-id pub-id-type="pmid">20493917</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>LK</given-names></name><name><surname>Guan</surname><given-names>L</given-names></name><name><surname>Damanhuri</surname><given-names>H</given-names></name><name><surname>Goodchild</surname><given-names>AK</given-names></name><name><surname>Bobrovskaya</surname><given-names>L</given-names></name><name><surname>Dickson</surname><given-names>PW</given-names></name><name><surname>Dunkley</surname><given-names>PR</given-names></name></person-group><article-title>Neurobiological consequences of acute footshock stress: effects on tyrosine hydroxylase phosphorylation and activation in the rat brain and adrenal medulla</article-title><source>J Neurochem</source><year>2014</year><volume>128</volume><fpage>547</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">24117713</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Ong LK, Guan L, Damanhuri H, Goodchild AK, Bobrovskaya L, Dickson PW, Dunkley PR (2014) Neurobiological consequences of acute footshock stress: effects on tyrosine hydroxylase phosphorylation and activation in the rat brain and adrenal medulla. J Neurochem 128:547&#x02013;560<pub-id pub-id-type="pmid">24117713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>LK</given-names></name><name><surname>Guan</surname><given-names>L</given-names></name><name><surname>Stutz</surname><given-names>B</given-names></name><name><surname>Dickson</surname><given-names>PW</given-names></name><name><surname>Dunkley</surname><given-names>PR</given-names></name><name><surname>Bobrovskaya</surname><given-names>L</given-names></name></person-group><article-title>The effects of footshock and immobilization stress on tyrosine hydroxylase phosphorylation in the rat locus coeruleus and adrenal gland</article-title><source>Neuroscience</source><year>2011</year><volume>192</volume><fpage>20</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">21767616</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Ong LK, Guan L, Stutz B, Dickson PW, Dunkley PR, Bobrovskaya L (2011) The effects of footshock and immobilization stress on tyrosine hydroxylase phosphorylation in the rat locus coeruleus and adrenal gland. Neuroscience 192:20&#x02013;27<pub-id pub-id-type="pmid">21767616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Senthilkumaran</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Bobrovskaya</surname><given-names>L</given-names></name></person-group><article-title>The effects of insulin-Induced Hypoglycaemia on Tyrosine hydroxylase phosphorylation in rat brain and adrenal gland</article-title><source>Neurochem Res</source><year>2016</year><volume>41</volume><fpage>1612</fpage><lpage>1624</lpage><pub-id pub-id-type="pmid">26935743</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Senthilkumaran M, Johnson ME, Bobrovskaya L (2016) The effects of insulin-Induced Hypoglycaemia on Tyrosine hydroxylase phosphorylation in rat brain and adrenal gland. Neurochem Res 41:1612&#x02013;1624<pub-id pub-id-type="pmid">26935743</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Dunkley</surname><given-names>PR</given-names></name><name><surname>Dickson</surname><given-names>PW</given-names></name></person-group><article-title>Tyrosine hydroxylase phosphorylation in vivo</article-title><source>J Neurochem</source><year>2019</year><volume>149</volume><fpage>706</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">30714137</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Dunkley PR, Dickson PW (2019) Tyrosine hydroxylase phosphorylation in vivo. J Neurochem 149:706&#x02013;728<pub-id pub-id-type="pmid">30714137</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Lonze</surname><given-names>BE</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name></person-group><article-title>Function and regulation of CREB family transcription factors in the nervous system</article-title><source>Neuron</source><year>2002</year><volume>35</volume><fpage>605</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">12194863</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605&#x02013;623<pub-id pub-id-type="pmid">12194863</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis-Tuffin</surname><given-names>LJ</given-names></name><name><surname>Quinn</surname><given-names>PG</given-names></name><name><surname>Chikaraishi</surname><given-names>DM</given-names></name></person-group><article-title>Tyrosine hydroxylase transcription depends primarily on cAMP response element activity, regardless of the type of inducing stimulus</article-title><source>Mol Cell Neurosci</source><year>2004</year><volume>25</volume><fpage>536</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">15033181</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Lewis-Tuffin LJ, Quinn PG, Chikaraishi DM (2004) Tyrosine hydroxylase transcription depends primarily on cAMP response element activity, regardless of the type of inducing stimulus. Mol Cell Neurosci 25:536&#x02013;547<pub-id pub-id-type="pmid">15033181</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><article-title>Neural plasticity: consequences of stress and actions of antidepressant treatment</article-title><source>Dialogues Clin Neurosci</source><year>2004</year><volume>6</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">22034207</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Duman RS (2004) Neural plasticity: consequences of stress and actions of antidepressant treatment. Dialogues Clin Neurosci 6:157&#x02013;169<pub-id pub-id-type="pmid">22034207</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Martinez</surname><given-names>S</given-names></name></person-group><article-title>A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis</article-title><source>Front Mol Neurosci</source><year>2015</year><volume>8</volume><fpage>46</fpage><pub-id pub-id-type="pmid">26379491</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Ortega-Martinez S (2015) A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis. Front Mol Neurosci 8:46<pub-id pub-id-type="pmid">26379491</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD (2004) Oxytocin attenuates stress-Induced <italic>c-fos</italic> mRNA expression in Specific Forebrain Regions Associated with Modulation of Hypothalamo&#x02013;pituitary&#x02013;adrenal activity. 24:2974&#x02013;2982</mixed-citation></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Huffmeijer</surname><given-names>R</given-names></name><name><surname>van Ijzendoorn</surname><given-names>MH</given-names></name><name><surname>Bakermans-Kranenburg</surname><given-names>MJ</given-names></name></person-group><article-title>Ageing and oxytocin: a call for extending human oxytocin research to ageing populations&#x02013;a mini-review</article-title><source>Gerontology</source><year>2013</year><volume>59</volume><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">22922544</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Huffmeijer R, van Ijzendoorn MH, Bakermans-Kranenburg MJ (2013) Ageing and oxytocin: a call for extending human oxytocin research to ageing populations&#x02013;a mini-review. Gerontology 59:32&#x02013;39<pub-id pub-id-type="pmid">22922544</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Tampi</surname><given-names>RR</given-names></name><name><surname>Maksimowski</surname><given-names>M</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>Tampi</surname><given-names>DJ</given-names></name></person-group><article-title>Oxytocin for frontotemporal dementia: a systematic review</article-title><source>Ther Adv Psychopharmacol</source><year>2017</year><volume>7</volume><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">28101324</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Tampi RR, Maksimowski M, Ahmed M, Tampi DJ (2017) Oxytocin for frontotemporal dementia: a systematic review. Ther Adv Psychopharmacol 7:48&#x02013;53<pub-id pub-id-type="pmid">28101324</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PR</given-names></name><name><surname>Brady</surname><given-names>DL</given-names></name><name><surname>Shapiro</surname><given-names>RA</given-names></name><name><surname>Dorsa</surname><given-names>DM</given-names></name><name><surname>Koenig</surname><given-names>JI</given-names></name></person-group><article-title>Prenatal stress generates deficits in rat social behavior: reversal by oxytocin</article-title><source>Brain Res</source><year>2007</year><volume>1156</volume><fpage>152</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">17540347</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI (2007) Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res 1156:152&#x02013;167<pub-id pub-id-type="pmid">17540347</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Rault</surname><given-names>JL</given-names></name><name><surname>Mack</surname><given-names>LA</given-names></name><name><surname>Carter</surname><given-names>CS</given-names></name><name><surname>Garner</surname><given-names>JP</given-names></name><name><surname>Marchant-Forde</surname><given-names>JN</given-names></name><name><surname>Richert</surname><given-names>BT</given-names></name><name><surname>Lay</surname><given-names>DC</given-names></name></person-group><article-title>Prenatal stress puzzle, the oxytocin piece: prenatal stress alters the behaviour and autonomic regulation in piglets, insights from oxytocin</article-title><source>Appl Anim Behav Sci</source><year>2013</year><volume>148</volume><fpage>99</fpage><lpage>107</lpage></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Rault JL, Mack LA, Carter CS, Garner JP, Marchant-Forde JN, Richert BT, Lay DC (2013) Prenatal stress puzzle, the oxytocin piece: prenatal stress alters the behaviour and autonomic regulation in piglets, insights from oxytocin. Appl Anim Behav Sci 148:99&#x02013;107</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Florea T, Palimariciuc M, Cristofor AC, Dobrin I, Chirita R, Birsan M, Dobrin RP, Padurariu M (2022) Oxytocin: Narrative expert review of current perspectives on the relationship with other neurotransmitters and the impact on the Main Psychiatric disorders. Med (Kaunas) 58</mixed-citation></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Grieb</surname><given-names>ZA</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Stoehr</surname><given-names>MC</given-names></name><name><surname>Horne</surname><given-names>BW</given-names></name><name><surname>Norvelle</surname><given-names>A</given-names></name><name><surname>Shaughnessy</surname><given-names>EK</given-names></name><name><surname>Albers</surname><given-names>HE</given-names></name><name><surname>Huhman</surname><given-names>KL</given-names></name></person-group><article-title>Sex-dependent regulation of social avoidance by oxytocin signaling in the ventral tegmental area</article-title><source>Behav Brain Res</source><year>2024</year><volume>462</volume><fpage>114881</fpage><pub-id pub-id-type="pmid">38272188</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Grieb ZA, Lee S, Stoehr MC, Horne BW, Norvelle A, Shaughnessy EK, Albers HE, Huhman KL (2024) Sex-dependent regulation of social avoidance by oxytocin signaling in the ventral tegmental area. Behav Brain Res 462:114881<pub-id pub-id-type="pmid">38272188</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Rappeneau</surname><given-names>V</given-names></name><name><surname>Castillo Diaz</surname><given-names>F</given-names></name></person-group><article-title>Convergence of oxytocin and dopamine signalling in neuronal circuits: insights into the neurobiology of social interactions across species</article-title><source>Neurosci Biobehav Rev</source><year>2024</year><volume>161</volume><fpage>105675</fpage><pub-id pub-id-type="pmid">38608828</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Rappeneau V, Castillo Diaz F (2024) Convergence of oxytocin and dopamine signalling in neuronal circuits: insights into the neurobiology of social interactions across species. Neurosci Biobehav Rev 161:105675<pub-id pub-id-type="pmid">38608828</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>J</given-names></name><name><surname>Enkhjargal</surname><given-names>B</given-names></name><name><surname>Travis</surname><given-names>ZD</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Ocak</surname><given-names>U</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>JH</given-names></name></person-group><article-title>AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats</article-title><source>Redox Biol</source><year>2018</year><volume>20</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">30296700</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Mo J, Enkhjargal B, Travis ZD, Zhou K, Wu P, Zhang G, Zhu Q, Zhang T, Peng J, Xu W, Ocak U, Chen Y, Tang J, Zhang J, Zhang JH (2018) AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats. Redox Biol 20:75&#x02013;86<pub-id pub-id-type="pmid">30296700</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Jovanovic</surname><given-names>P</given-names></name><name><surname>Stefanovic</surname><given-names>B</given-names></name><name><surname>Spasojevic</surname><given-names>N</given-names></name><name><surname>Puskas</surname><given-names>N</given-names></name><name><surname>Dronjak</surname><given-names>S</given-names></name></person-group><article-title>Effects of oxytocin on adreno-medullary catecholamine synthesis, uptake and storage in rats exposed to chronic isolation stress</article-title><source>Endocr Res</source><year>2016</year><volume>41</volume><fpage>124</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">26726927</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Jovanovic P, Stefanovic B, Spasojevic N, Puskas N, Dronjak S (2016) Effects of oxytocin on adreno-medullary catecholamine synthesis, uptake and storage in rats exposed to chronic isolation stress. Endocr Res 41:124&#x02013;131<pub-id pub-id-type="pmid">26726927</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>FY</given-names></name><name><surname>Matsunaga</surname><given-names>T</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Kaitsuka</surname><given-names>T</given-names></name><name><surname>Tomizawa</surname><given-names>K</given-names></name></person-group><article-title>Oxytocin protects against stress-Induced cell death in murine pancreatic beta-cells</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>25185</fpage><pub-id pub-id-type="pmid">27143105</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Watanabe S, Wei FY, Matsunaga T, Matsunaga N, Kaitsuka T, Tomizawa K (2016) Oxytocin protects against stress-Induced cell death in murine pancreatic beta-cells. Sci Rep 6:25185<pub-id pub-id-type="pmid">27143105</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YT</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Hsu</surname><given-names>KS</given-names></name></person-group><article-title>Oxytocin promotes long-term potentiation by enhancing epidermal growth factor receptor-mediated local translation of protein kinase M&#x003b6;</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>15476</fpage><lpage>15488</lpage><pub-id pub-id-type="pmid">23115185</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Lin YT, Huang CC, Hsu KS (2012) Oxytocin promotes long-term potentiation by enhancing epidermal growth factor receptor-mediated local translation of protein kinase M&#x003b6;. J Neurosci 32:15476&#x02013;15488<pub-id pub-id-type="pmid">23115185</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Tomizawa</surname><given-names>K</given-names></name><name><surname>Iga</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>YF</given-names></name><name><surname>Moriwaki</surname><given-names>A</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>ST</given-names></name><name><surname>Miyamoto</surname><given-names>O</given-names></name><name><surname>Itano</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name></person-group><article-title>Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade</article-title><source>Nat Neurosci</source><year>2003</year><volume>6</volume><fpage>384</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">12598900</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Tomizawa K, Iga N, Lu YF, Moriwaki A, Matsushita M, Li ST, Miyamoto O, Itano T, Matsui H (2003) Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci 6:384&#x02013;390<pub-id pub-id-type="pmid">12598900</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Lochner</surname><given-names>A</given-names></name><name><surname>Moolman</surname><given-names>JA</given-names></name></person-group><article-title>The many faces of H89: a review</article-title><source>Cardiovasc Drug Rev</source><year>2006</year><volume>24</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">17214602</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Lochner A, Moolman JA (2006) The many faces of H89: a review. Cardiovasc Drug Rev 24:261&#x02013;274<pub-id pub-id-type="pmid">17214602</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Zatkova</surname><given-names>M</given-names></name><name><surname>Reichova</surname><given-names>A</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name></person-group><article-title>Activation of the oxytocin receptor modulates the expression of synaptic adhesion molecules in a cell-specific manner</article-title><source>J Mol Neurosci</source><year>2019</year><volume>68</volume><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">30888622</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Zatkova M, Reichova A, Bacova Z, Bakos J (2019) Activation of the oxytocin receptor modulates the expression of synaptic adhesion molecules in a cell-specific manner. J Mol Neurosci 68:171&#x02013;180<pub-id pub-id-type="pmid">30888622</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Lestanova</surname><given-names>Z</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Havranek</surname><given-names>T</given-names></name><name><surname>Strbak</surname><given-names>V</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name></person-group><article-title>Oxytocin increases neurite length and expression of Cytoskeletal Proteins Associated with neuronal growth</article-title><source>J Mol Neurosci</source><year>2016</year><volume>59</volume><fpage>184</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">26474566</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Lestanova Z, Bacova Z, Kiss A, Havranek T, Strbak V, Bakos J (2016) Oxytocin increases neurite length and expression of Cytoskeletal Proteins Associated with neuronal growth. J Mol Neurosci 59:184&#x02013;192<pub-id pub-id-type="pmid">26474566</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>